Table 2.
Univariate logistic regression analysis of predictors of hypertension persistence after operation in training group.
| Variable | OR (95% CI) | P |
|---|---|---|
| Age | 1.03 (1.0–1.06) | 0.013 |
| Male | 2.60 (1.53–4.40) | < 0.001 |
| SBP | 1.02 (1.01–1.04) | < 0.001 |
| DBP | 1.02 (1.01–1.04) | 0.005 |
| BMI ≥ 25 | 3.16 (1.84–5.42) | < 0.001 |
| Duration of HT | 1.13 (1.07–1.19) | < 0.001 |
| Diabetes | 6.89 (2.74–17.34) | < 0.001 |
| HHD | 2.42 (1.33–4.43) | 0.004 |
| RH | 2.13 (1.24–3.66) | 0.060 |
| DDD of antihypertensive medication | 1.33 (1.12–1.73) | 0.002 |
| ARR | 0.42 (0.23–0.75) | 0.004 |
| PAC | 0.13 (0.04–0.40) | < 0.001 |
| DRC | 1.06 (0.94–1.20) | 0.347 |
| Lowest serum K+ | 1.62 (1.05–2.50) | 0.030 |
| eGFR | 0.98 (0.97–0.99) | < 0.001 |
| TG | 1.14 (0.94–1.39) | 0.178 |
| Diameter of nodule | 0.66 (0.46–0.94) | 0.022 |
Data are expressed as odds ratio (OR) (95% CI).
SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension, HHD hypertensive heart disease, RH resistant hypertension, DDD defined daily dose, ARR aldosterone/renin ratio, PAC plasma aldosterone concentration, DRC direct renin concentration, Lowest serum K+ lowest serum potassium in history, eGFR estimated glomerular filtration, TG triglyceride.